Eslicarbazepine
CAS No. 104746-04-5
Eslicarbazepine( BIA 2-194 )
Catalog No. M27993 CAS No. 104746-04-5
Eslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 140 | In Stock |
|
50MG | 215 | In Stock |
|
100MG | 335 | In Stock |
|
200MG | 494 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEslicarbazepine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures.
-
DescriptionEslicarbazepine can be used for adjunctive therapy for adults with partial-onset seizures.(In Vitro):Eslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual Inhibitor of β-Secretase and voltage-gated sodium channel.
-
In Vitro——
-
In VivoEslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.
-
SynonymsBIA 2-194
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorChitotriosidase (CHIT1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104746-04-5
-
Formula Weight254.289
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (983.17 mM)
-
SMILESNC(=O)N1c2ccccc2C[C@H](O)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mazur M, et al. Discovery of selective, orally bioavailable inhibitor of mouse chitotriosidase. Bioorg Med Chem Lett. 2018 Feb 1;28(3):310-314.
molnova catalog
related products
-
PF-04885614
PF-04885614 is a potent inhibitor of NaV1.8, has potential for neurological and neurodevelopmental diseases treatment.
-
PF-05089771
PF-05089771 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 11 nM.
-
Oxybuprocaine hydroc...
Oxybuprocaine hydrochloride is a local anesthetic, which is used especially in ophthalmology and otolaryngology.